A
Ank E. Vriesendorp
Researcher at University of Texas Southwestern Medical Center
Publications - 1
Citations - 99
Ank E. Vriesendorp is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Renal function & Heart transplantation. The author has an hindex of 1, co-authored 1 publications receiving 92 citations.
Papers
More filters
Journal ArticleDOI
Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation.
Paul B. Rosenberg,Paul B. Rosenberg,Ank E. Vriesendorp,Mark H. Drazner,Mark H. Drazner,Daniel L. Dries,Patricia A. Kaiser,Linda S. Hynan,J. Michael DiMaio,J. Michael DiMaio,Dan M. Meyer,Dan M. Meyer,W. Steves Ring,W. Steves Ring,Clyde W. Yancy,Clyde W. Yancy +15 more
TL;DR: Basiximab induction therapy allows delayed initiation of cyclosporine after cardiac transplantation without an increase in rejection and reduces the risk of post-operative renal dysfunction.